Suspendido

Mechanisms of Response to Diesel Exhaust in Subjects With Asthma

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Colección de datos

Quiénes están siendo reclutados

Enfermedades bronquiales+6

+ Hipersensibilidad

+ Hipersensibilidad inmediata

De 18 a 55 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Caso Cruzado

Comparación de exposiciones durante la aparición y la no aparición de la enfermedad para evaluar los efectos a corto plazo de ciertos desencadenantes.
Observacional
Inicio del estudio: marzo de 2013
Ver detalles del protocolo

Resumen

Patrocinador PrincipalUniversity of Pennsylvania
Última actualización: 10 de abril de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de marzo de 2013

Fecha en la que se inscribió al primer participante.

The investigators will also characterize selected polymorphisms in glutathione-S-transferase (GST) genes that have been implicated in susceptibility to air pollutants. Outcome measures will include lung function, bronchial responsiveness to bronchodilator, exhaled nitric oxide, induced sputum for inflammatory markers (IL6 and IL8), and exhaled breath condensate for nitrite, 8-isoprostane, 20-HETE (20-hydroxyeicosatetraenoic acid), nitrotyrosine and pH. In this pilot project, parallel studies are being carried out in the human exposure chambers at two NIEHS centers, the EOHSI-CEED (Environmental and Occupational Health Sciences Institute- Center for Environmental Exposure and Disease) and the Penn-CEET (University of Pennsylvania-Center of Excellence in Environmental Toxicology). The joint project will enable each center to validate research results in a second population and include new biomarkers of pulmonary inflammation. Each center will recruit, consent, and collect data on its own subjects. Only de-identified data will be shared between the centers.

Patrocinador PrincipalUniversity of Pennsylvania
Última actualización: 10 de abril de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.

Caso Cruzado

En este diseño, los participantes actúan como su propio control. Los investigadores comparan las exposiciones justo antes de un evento de salud con otros momentos, para identificar desencadenantes o riesgos a corto plazo.

Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

De 18 a 55 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos no permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Enfermedades bronquialesHipersensibilidadHipersensibilidad inmediataEnfermedades del sistema inmunitarioEnfermedades del pulmónEnfermedades Pulmonares ObstructivasHipersensibilidad RespiratoriaEnfermedades del Tracto RespiratorioAsma

Criterios

Inclusion Criteria: Subject is an adult male or female between 18 and 55 years of age inclusive. Subject must have a prior history of a physician's diagnosis of asthma with reversible airway obstruction (shown by a greater than 12% increase in FEV1 following bronchodilator; or a positive methacholine challenge done following the screening visit. If methacholine challenge is required for qualification, a physician will be on-site for the test. Subject's asthma has been stable for the past six months with no change in asthma therapy. The subject has been a non-smoker for the past year and should have less than a 10-pack year history. Subject must be free of other significant pulmonary diseases (i.e., cystic fibrosis, tuberculosis, interstitial lung disease and bronchopulmonary dysplasia. The subject must be capable of and willing to provide written informed consent. The subject is able to understand and comply with protocol requirements and timetables, instructions and protocol-stated restrictions. The subject has no significant DE exposure that would include occupations such as truck driver, heavy equipment operator and railroad maintenance. - Exclusion Criteria: As a result of the medical interview, physical examination or screening investigations, the physician responsible considers the volunteer unfit for the study. The subject has received an investigational drug or participated in any other research trial within 30 days or five half-lives or twice the duration of the biological effect of any drug (whichever is longer) prior to the current study. Oral steroids within the last 6 months. Less than 12% FEV1 response to bronchodilator or negative methacholine challenge. Hospital admission for asthma in past 6 months. The subject has a history of alcohol or drug abuse within the last 5 years. The subject has history of hepatitis B, hepatitis C or HIV virus. The subject has a history of cardiovascular disease including hypertension or says yes to one of the cardiovascular risk questions on the screening questionnaire. The subject has a history of diabetes. The subject is pregnant or lactating. The subject has daily exposure to DE, i.e., trucking or heavy machine operators. -

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Objetivos del Estudio

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene una ubicación

Airways Biology Initiative at Penn Presbyterian Medical Center

Philadephia, United StatesAbrir Airways Biology Initiative at Penn Presbyterian Medical Center en Google Maps
Suspendido1 Centros de Estudio